Home › Stocks › NRSN › Changes

Who bought & sold NRSN (Q2 2026)

Funds holding (Q2 2026)13
New positions3
Added2
Reduced2
Exited3

As of Q2 2026, 13 institutional funds reported holding NRSN (NEUROSENSE THERAPEUTICS LTD): 3 opened new positions, 2 added, 2 trimmed and 3 exited entirely. 13F filings are quarter-end snapshots of positioning, not intra-quarter trades.

New positions (3)

Fund Shares Value Weight
GEODE CAPITAL MANAGEMENT, LLC New 15.87K $11.43K —
XTX Topco Ltd New 11.47K $8.26K —
HRT FINANCIAL LP New 10.52K $7.00K —

Added to positions (2)

Fund Shares Value Weight Change
UBS Group AG 108.64K $78.22K — +59.54K sh (+121.3%)
Independent Advisor Alliance 100.00K $72.00K 0.0 +50.00K sh (+100.0%)

Reduced positions (2)

Fund Shares Value Weight Change
Creative Planning 11.41K $8.21K — -501 sh (-4.2%)
SBI Securities Co., Ltd. 255 $184 — -10 sh (-3.8%)

Exited positions (3)

Held in the prior quarter but not reported in the latest filing.

Fund Shares Value Weight
Two Sigma Investments Exited 44.45K $33.56K —
MEITAV INVESTMENT HOUSE LTD Exited 40.00K $30.20K —
JANE STREET GROUP, LLC Exited 28.67K $21.65K —